Literature DB >> 562852

Lymphocyte activation by various Mycoplasma strains and species.

Y Naot, J G Tully, H Ginsburg.   

Abstract

The capacity of various mycoplasma strains and species to induce lymphocyte transformation in vitro was studied. Of six strains of Mycoplasma pulmonis studied, five displayed mitogenic activity with rat lymphocytes. Among those M. pulmonis strains, our MP15 isolate and the Negroni strain exhibited particularly potent mitogenic capacity. The murine mycoplasmas M. neurolyticum and M. arthritidis shared this mitogenicity for rat lymphocytes. However, the human mycoplasmas M. fermentans, M. pneumoniae, M. hominis, M. orale, and Acholeplasma laidlawii did not activate rat lymphocytes. Lymphocytes obtained from germfree rats were activated to the same extent as those from animals bred under conventional conditions. The mitogenic potency exhibited by mycoplasma was not restricted to infective microorganisms, and preparations of killed mycoplasma particles exerted an extensive lymphocyte transformation. The data show that the mitogenic activity of mycoplasmas is not confined to a single mycoplasma isolate and that it acts in a nonspecific manner.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562852      PMCID: PMC421232          DOI: 10.1128/iai.18.2.310-317.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Mycoplasma pneumoniae is a polyclonal B-cell activator.

Authors:  G Biberfeld; E Gronowicz
Journal:  Nature       Date:  1976-05-20       Impact factor: 49.962

2.  Extensive transformation of lymphocytes by a mycoplasma organism.

Authors:  H Ginsburg; J Nicolet
Journal:  Nat New Biol       Date:  1973-12-05

3.  Natural infection of germfree rats with Mycoplasma pulmonis.

Authors:  J R Ganaway; A M Allen; T D Moore; H J Bohner
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

Review 4.  Mycoplasmas and cell cultures.

Authors:  E Stanbridge
Journal:  Bacteriol Rev       Date:  1971-06

5.  Effects of L-asparaginase on lymphocyte-target cell reactions in vitro.

Authors:  M C Berenbaum; H Ginsburg; D M Gilbert
Journal:  Nature       Date:  1970-09-12       Impact factor: 49.962

6.  Serological heterogeneity of Mycoplasma pulmonis.

Authors:  K A Forshaw; R J Fallon
Journal:  J Gen Microbiol       Date:  1972-10

7.  Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis.

Authors:  J R Lindsey; H J Baker; R G Overcash; G H Cassell; C E Hunt
Journal:  Am J Pathol       Date:  1971-09       Impact factor: 4.307

8.  Experimental arthritis in mice with Mycoplasma pulmonis.

Authors:  J A Barden; J G Tully
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

9.  [Factors influencing the susceptibility of mice to Mycoplasma arthritidis].

Authors:  B C Cole; J R Ward; L Golightly-Rowland
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

10.  Arthritis of mice induced by Mycoplasma arthritidis. Humoral antibody and lymphocyte responses of CBA mice.

Authors:  B C Cole; L Golightly-Rowland; J R Ward
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

View more
  22 in total

1.  Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.

Authors:  Farhan S Cyprian; Steve Jimbo; Muhammad Suleman; Teresia Maina; Tracy Prysliak; Claire Windeyer; Jose Perez-Casal
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

2.  Domain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motility.

Authors:  How-Yi Chang; Jarrat L Jordan; Duncan C Krause
Journal:  J Bacteriol       Date:  2011-01-21       Impact factor: 3.490

3.  Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences.

Authors:  J K Davis; J W Simecka; J S Williamson; S E Ross; M M Juliana; R B Thorp; G H Cassell
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

4.  Protein variability among strains of Mycoplasma pulmonis.

Authors:  H L Watson; M K Davidson; N R Cox; J K Davis; K Dybvig; G H Cassell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis.

Authors:  H L Watson; L S McDaniel; D K Blalock; M T Fallon; G H Cassell
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Mitogenicity of Mycoplasma fermentans for human lymphocytes.

Authors:  E Nilsson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Monoclonal antibodies that inhibit mitogenic activity of Mycoplasma pulmonis.

Authors:  Z Lapidot; R Siman-Tov; Y Naot
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes.

Authors:  Y Naot; S Merchav; E Ben-David; H Ginsburg
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

10.  Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination.

Authors:  F C Minion; G H Cassell; S Pnini; I Kahane
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.